powered by
▸
healthparse
Search
Cohort Builder
Tools
▾
KOL Finder
Territories
Drug Compare
AI Query
Research
Browse
▾
By state
By specialty
Pricing
Search
Cohort Builder
Tools
KOL Finder
Territories
Drug Compare
AI Query
Research
Browse
By state
By specialty
Pricing
PROVIDER PROFILE · NPI 1124475751
Tanvisha Mody
MD
Endocrinology
New Hyde Park,
NY
I
CROSS-REFERENCE
Related data on other Healthparse brands
ProviderScore
OIG/SAM exclusion screening, sanctions history
Healthparse Signals
Monitor this provider for changes — dated NPI change events
FACILITY AFFILIATIONS
Hospital & Facility Affiliations (1)
CCN 330106
Hospital
PRESCRIBING · PART D · 2024
Total Rx claims
1,889
Beneficiaries
—
Total drug cost
$1.3M
Distinct drugs
26
Brand share
69.3%
Top prescribed drugs
Semaglutide
218 claims
Levothyroxine Sodium
153 claims
Glimepiride
140 claims
Tirzepatide
131 claims
Metformin Hcl
123 claims
QUALITY · MIPS · 2024
Final MIPS score
82.1
Quality
72.1
Cost
75.8
Improvement activities
40.0
Promoting interop.
91.0
Payment adjustment
0.30%
Group
MEDICARE UTILIZATION · PART B · 2024
Total beneficiaries
1,548
Unique beneficiaries
—
Total services
4,795
Distinct HCPCS
19
Medicare payment
$256K
Peer benchmark
Q1
Q2
Q3
Q4
Q5
Total Medicare services vs. 627 Endocrinology providers in NY — top quintile (cohort median 837).
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024
Total received
$20
Payment records
1
By payment type
Food and Beverage
$20
Top paying entities
Food and Beverage
$20
